# Safety Study of FLP Injection to Treat Tumor Patients

> **NCT01361529** · PHASE1 · UNKNOWN · sponsor: **Acea Bio (Hangzhou) Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** FLP,dose escalation,MTD

## Key facts

- **NCT ID:** NCT01361529
- **Lead sponsor:** Acea Bio (Hangzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361529, "Safety Study of FLP Injection to Treat Tumor Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01361529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*